COSGRAVE MICHAEL 4

Accession 0000899140-04-001427

CIK 0001203866other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 12:52 PM ET

Size

36.1 KB

Accession

0000899140-04-001427

Insider Transaction Report

Form 4

Period: 2004-12-13

PHARMION CORPPHRM

COSGRAVE MICHAEL

Vice President

Transactions

Sale
Common Stock
2004-12-13$47.40/sh−21,415$1,015,071→ 22,961 total
Sale
Common Stock
2004-12-14$47.40/sh−500$23,700→ 22,461 total
Sale
Common Stock
2004-12-14$47.20/sh−1,500$70,800→ 20,961 total
Sale
Common Stock
2004-12-14$47.00/sh−8,300$390,100→ 12,661 total
Exercise/Conversion
Common Stock
2004-12-13$1.60/sh+4,843$7,749→ 26,093 total
Exercise/Conversion
Common Stock
2004-12-13$2.40/sh+22,160$53,184→ 48,253 total
Exercise/Conversion
Common Stock
2004-12-13$13.67/sh+9,375$128,156→ 57,628 total
Sale
Common Stock
2004-12-13$47.68/sh−3,000$143,040→ 54,628 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-12-13−22,160→ 24,090 total
Exercise: $2.40From: 2002-12-09Exp: 2009-12-09→ Common Stock (22,160 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2004-12-13−9,375→ 28,125 total
Exercise: $13.67Exp: 2010-12-02→ Common Stock (9,375 underlying)
Exercise/Conversion
Common Stock
2004-12-13$0.40/sh+21,250$8,500→ 21,250 total
Sale
Common Stock
2004-12-14$46.97/sh−1,000$46,970→ 11,661 total
Sale
Common Stock
2004-12-14$46.85/sh−4,000$187,400→ 7,661 total
Sale
Common Stock
2004-12-13$47.60/sh−7,252$345,195→ 47,376 total
Sale
Common Stock
2004-12-14$46.71/sh−2,000$93,420→ 5,661 total
Sale
Common Stock
2004-12-14$46.53/sh−2,161$100,551→ 3,500 total
Sale
Common Stock
2004-12-14$46.50/sh−2,500$116,250→ 1,000 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-12-13−21,250→ 0 total
Exercise: $0.40From: 2000-11-13Exp: 2007-11-13→ Common Stock (21,250 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2004-12-13−4,843→ 2,657 total
Exercise: $1.60From: 2002-04-23Exp: 2009-04-23→ Common Stock (4,843 underlying)

Footnotes (3)

[F1]The option was immediately exercisable as to both vested and unvested shares. The grant consisted of an option to purchase 7,500 shares of Common Stock and continues to vest as follows: 25% vested on April 23, 2003 (the one year anniversary of the date of grant) and 1/48 of the remainder vests monthly thereafter. To the extent the reporting person exercises the option as to unvested shares, such shares will be subject to a repurchase right held by the Issuer, which right will lapse in accordance with the vesting schedule for the option grant. The partial exercise of the option described herein related only to fully vested shares.
[F2]The option was immediately exercisable as to both vested and unvested shares. The grant consisted of an option to purchase 46,250 shares of Common Stock and continues to vest as follows: 25% vested on December 9, 2003 (the one year anniversary of the date of grant) and 1/48 of the remainder vests monthly thereafter. To the extent the reporting person exercises the option as to unvested shares, such shares will be subject to a repurchase right held by the Issuer, which right will lapse in accordance with the vesting schedule for the option grant. The partial exercise of the option described herein related only to fully vested shares.
[F3]The option is exercisable in accordance with its vesting schedule. Twenty-five percent of the shares vested on December 2, 2004 (the one year anniversary of the date of grant) and 1/48 of the remainder vests monthly thereafter.

Documents

1 file

4
cosgrave_pc4-121504ex.xmlPrimary

Issuer

PHARMION CORP

CIK 0001203866

→

Entity typeother

Related Parties

filerCIK 0001268375

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 12:52 PM ET
Size: 36.1 KB

View on SEC.gov